LIMERICK, Ireland, Oct. 31, 2024 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a global and diverse medical devices manufacturer h
The Company provides solutions to the pharma, biotech and cosmetic industries, including pharmaceutical primary packaging, drug delivery systems, diagnostic and medical devices, and digital healthcare solutions. Headquartered in Germany, the Company employs more than 11,000 people and operates over 30 production sites in 15 countries across Europe, Asia and the Americas. The company plans to use the Kneat Gx platform initially for Commissioning, Qualification and Validation (CQV). Read More
